Toho Holdings Co (FRA:TON) 3-Year RORE % : -9.69% (As of Mar. 2026)


FRA:TON Toho Holdings Co Ltd FRA:TON
26 GF Score
Price €21.40
GF Value €26.10
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Toho Holdings Co 3-Year RORE %?

Toho Holdings Co FRA:TON 26 3-Year RORE % is -9.69 as of Mar. 2026. GuruFocus rates FRA:TON with a GF Score™ of 26/100 and a GF Value™ of €26.10 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 111 Medical Distribution companies, Toho Holdings Co ranks worse than 66.67% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Toho Holdings Co's 3-Year RORE % for the quarter that ended in Mar. 2026 was -9.69%.

The industry rank for Toho Holdings Co's 3-Year RORE % or its related term are showing as below:

FRA:TON's 3-Year RORE % is ranked worse than
66.67% of 111 companies
in the Medical Distribution industry
Industry Median: 14.45 vs FRA:TON: -9.69

Toho Holdings Co  (FRA:TON) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Toho Holdings Co 3-Year RORE % Related Terms


Toho Holdings Co 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Toho Holdings Co's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Toho Holdings Co 3-Year RORE % Chart

Toho Holdings Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.82 30.82 12.44 12.45 -9.69

Toho Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.45 17.04 3.31 12.26 -9.69

FRA:TON vs MCK, CAH, COR: 3-Year RORE % Comparison

For the Medical Distribution subindustry, Toho Holdings Co's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Toho Holdings Co 3-Year RORE % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Toho Holdings Co's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Toho Holdings Co's 3-Year RORE % falls into.


FRA:TON
26GF Score
Toho Holdings Co Ltd FRA:TON
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Toho Holdings Co 3-Year RORE % Calculation

Toho Holdings Co's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 1.466-1.804 )/( 5.031-1.543 )
=-0.338/3.488
=-9.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -9.69 mean?
Toho Holdings Co (FRA:TON) has a 3-Year RORE % of -9.69 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Toho Holdings Co and its competitors. According to the industry distribution chart, Toho Holdings Co ranks #74 out of 111 companies in the Medical Distribution industry, placing it in the top 66.7%.
Is Toho Holdings Co's 3-Year RORE % too high?
Toho Holdings Co's current 3-Year RORE % is -9.69. Based on the distribution chart, Toho Holdings Co ranks #74 out of 111 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Toho Holdings Co has a GF Score™ of 26/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Toho Holdings Co's 3-Year RORE % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Toho Holdings Co ranks #74 out of 111 companies for 3-Year RORE %. This places Toho Holdings Co in the lower half of its industry. The industry median 3-Year RORE % is 14.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Distribution company?
The median 3-Year RORE % among Medical Distribution companies is 14.45, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Toho Holdings Co and its competitors. For the Medical Distribution industry, the median 3-Year RORE % is 14.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Toho Holdings Co's current 3-Year RORE % is -9.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Toho Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Toho Holdings Co (FRA:TON) is currently considered Modestly Undervalued. The stock's GF Value™ is €26.10, compared to a current price of €21.40 — trading 18% below its estimated fair value. The current 3-Year RORE % is -9.69. Toho Holdings Co's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Toho Holdings Co (FRA:TON), the current 3-Year RORE % is -9.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Toho Holdings Co (FRA:TON) Overvalued in 2026?

Based on GuruFocus' analysis, Toho Holdings Co stock appears to be undervalued. The current stock price of €21.40 is trading 18% below its estimated GF Value™ of €26.10. GuruFocus considers Toho Holdings Co to be Modestly Undervalued.

Key valuation signals for FRA:TON:

  • 3-Year RORE %: -9.69
  • GF Value™: €26.10 vs. price of €21.40 (18% below fair value)
  • GF Score™: 26/100 with 3 warning signs

No single metric tells the full story. See the FRA:TON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Toho Holdings Co Business Description

Other Exchanges 8129:Japan
Address 4-43-11 Daizawa, Setagaya-ku, Tokyo, JPN, 155-8655
Toho Holdings Co Ltd is a specialty and generic drug manufacturing company. The company's business includes pharmaceutical wholesaling and pharmacy dispensing. It also maintains a site-management organization business that assists a variety of medical establishments, ranging from large medical institutions to private clinics, with a wide range of clinical trials under contract. The company supports medical institutions suitable for respective trials to improve the quality and speed of clinical trials. It generates additional revenue through software sales to medical institutions.
26GF Score

Get the complete analysis for FRA:TON

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.40
Price
€26.10
GF Value